company background image
VTI

Visioneering TechnologiesASX:VTI Stock Report

Market Cap

AU$23.5m

7D

3.1%

1Y

-75.7%

Updated

20 Oct, 2021

Data

Company Financials +
VTI fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

VTI Overview

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific.

Visioneering Technologies Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Visioneering Technologies
Historical stock prices
Current Share PriceAU$0.99
52 Week HighAU$0.94
52 Week LowAU$4.20
Beta1.66
1 Month Change5.85%
3 Month Change-11.16%
1 Year Change-75.73%
3 Year Change-94.47%
5 Year Changen/a
Change since IPO-97.76%

Recent News & Updates

Sep 23
Health Check: How Prudently Does Visioneering Technologies (ASX:VTI) Use Debt?

Health Check: How Prudently Does Visioneering Technologies (ASX:VTI) Use Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Shareholder Returns

VTIAU Medical EquipmentAU Market
7D3.1%3.0%1.7%
1Y-75.7%-6.5%20.2%

Return vs Industry: VTI underperformed the Australian Medical Equipment industry which returned -6.5% over the past year.

Return vs Market: VTI underperformed the Australian Market which returned 20.2% over the past year.

Price Volatility

Is VTI's price volatile compared to industry and market?
VTI volatility
VTI Beta1.66
Industry Beta0.57
Market Beta1

Stable Share Price: VTI is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: VTI's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2008n/aStephen Snowdyhttps://vtivision.com

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. It offers NaturalVue, a multifocal contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

Visioneering Technologies Fundamentals Summary

How do Visioneering Technologies's earnings and revenue compare to its market cap?
VTI fundamental statistics
Market CapUS$17.58m
Earnings (TTM)-US$5.55m
Revenue (TTM)US$6.18m

2.8x

P/S Ratio

-3.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
VTI income statement (TTM)
RevenueUS$6.18m
Cost of RevenueUS$5.18m
Gross ProfitUS$1.01m
ExpensesUS$6.56m
Earnings-US$5.55m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.23
Gross Margin16.26%
Net Profit Margin-89.79%
Debt/Equity Ratio26.9%

How did VTI perform over the long term?

See historical performance and comparison

Valuation

Is Visioneering Technologies undervalued compared to its fair value and its price relative to the market?

1.63x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate VTI's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate VTI's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: VTI is unprofitable, so we can't compare its PE Ratio to the Australian Medical Equipment industry average.

PE vs Market: VTI is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate VTI's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: VTI is good value based on its PB Ratio (1.6x) compared to the AU Medical Equipment industry average (5x).


Future Growth

How is Visioneering Technologies forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

16.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: VTI is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: VTI is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: VTI is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: VTI's revenue (37.6% per year) is forecast to grow faster than the Australian market (5.4% per year).

High Growth Revenue: VTI's revenue (37.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: VTI is forecast to be unprofitable in 3 years.


Past Performance

How has Visioneering Technologies performed over the past 5 years?

12.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: VTI is currently unprofitable.

Growing Profit Margin: VTI is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: VTI is unprofitable, but has reduced losses over the past 5 years at a rate of 12.7% per year.

Accelerating Growth: Unable to compare VTI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: VTI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (74.9%).


Return on Equity

High ROE: VTI has a negative Return on Equity (-51.4%), as it is currently unprofitable.


Financial Health

How is Visioneering Technologies's financial position?


Financial Position Analysis

Short Term Liabilities: VTI's short term assets ($17.7M) exceed its short term liabilities ($4.6M).

Long Term Liabilities: VTI's short term assets ($17.7M) exceed its long term liabilities ($2.9M).


Debt to Equity History and Analysis

Debt Level: VTI's debt to equity ratio (26.9%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if VTI's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: VTI has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: VTI has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 0.2% each year.


Dividend

What is Visioneering Technologies's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate VTI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate VTI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if VTI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VTI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of VTI's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.1yrs

Average management tenure


CEO

Stephen Snowdy (51 yo)

8.33yrs

Tenure

US$331,013

Compensation

Dr. Stephen Snowdy, Ph D., has been Chief Executive Officer of Visioneering Technologies, Inc. June 2013, its Executive Director since November 25, 2008 and served as its President. Dr. Snowdy is a scienti...


CEO Compensation Analysis

Compensation vs Market: Stephen's total compensation ($USD331.01K) is about average for companies of similar size in the Australian market ($USD302.06K).

Compensation vs Earnings: Stephen's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: VTI's management team is considered experienced (4.1 years average tenure).


Board Members

Experienced Board: VTI's board of directors are considered experienced (3.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 142.6%.


Top Shareholders

Company Information

Visioneering Technologies, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Visioneering Technologies, Inc.
  • Ticker: VTI
  • Exchange: ASX
  • Founded: 2008
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: AU$23.517m
  • Shares outstanding: 23.64m
  • Website: https://vtivision.com

Number of Employees


Location

  • Visioneering Technologies, Inc.
  • 10745 Westside Way
  • Suite 200
  • Alpharetta
  • Georgia
  • 30009
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/20 15:29
End of Day Share Price2021/10/20 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.